| Product Code: ETC12750934 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Portugal`s nimodipine import market saw a shift in concentration from low to moderate in 2024, with top exporting countries including Austria, China, India, Netherlands, and Italy. Despite a significant negative Compound Annual Growth Rate (CAGR) of -19.77% from 2020 to 2024, the growth rate in 2024 alone showed a steep decline of -46.57%. This indicates potential challenges and changes in the market dynamics for nimodipine imports in Portugal, warranting a closer look at factors influencing this downward trend.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Nimodipine Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Nimodipine Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Nimodipine Market - Industry Life Cycle |
3.4 Portugal Nimodipine Market - Porter's Five Forces |
3.5 Portugal Nimodipine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Portugal Nimodipine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Portugal Nimodipine Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.8 Portugal Nimodipine Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Portugal Nimodipine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Portugal |
4.2.2 Growing awareness about the benefits of nimodipine for treating subarachnoid hemorrhage |
4.2.3 Rising healthcare expenditure and infrastructure development in Portugal |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Portugal |
4.3.2 Competition from alternative treatment options for neurological disorders |
4.3.3 Limited availability of skilled healthcare professionals specializing in neurology |
5 Portugal Nimodipine Market Trends |
6 Portugal Nimodipine Market, By Types |
6.1 Portugal Nimodipine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Portugal Nimodipine Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Portugal Nimodipine Market Revenues & Volume, By Immediate-Release, 2021 - 2031F |
6.1.4 Portugal Nimodipine Market Revenues & Volume, By Extended-Release, 2021 - 2031F |
6.1.5 Portugal Nimodipine Market Revenues & Volume, By Combination Drugs, 2021 - 2031F |
6.2 Portugal Nimodipine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Portugal Nimodipine Market Revenues & Volume, By Subarachnoid Hemorrhage, 2021 - 2031F |
6.2.3 Portugal Nimodipine Market Revenues & Volume, By Stroke Prevention, 2021 - 2031F |
6.2.4 Portugal Nimodipine Market Revenues & Volume, By Neurological Disorders, 2021 - 2031F |
6.3 Portugal Nimodipine Market, By Dosage Form |
6.3.1 Overview and Analysis |
6.3.2 Portugal Nimodipine Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.3.3 Portugal Nimodipine Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.3.4 Portugal Nimodipine Market Revenues & Volume, By Injection, 2021 - 2031F |
6.4 Portugal Nimodipine Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Portugal Nimodipine Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Portugal Nimodipine Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Portugal Nimodipine Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
7 Portugal Nimodipine Market Import-Export Trade Statistics |
7.1 Portugal Nimodipine Market Export to Major Countries |
7.2 Portugal Nimodipine Market Imports from Major Countries |
8 Portugal Nimodipine Market Key Performance Indicators |
8.1 Number of clinical trials conducted for nimodipine in Portugal |
8.2 Patient satisfaction rates with nimodipine treatment |
8.3 Adoption rate of nimodipine by healthcare institutions in Portugal |
9 Portugal Nimodipine Market - Opportunity Assessment |
9.1 Portugal Nimodipine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Portugal Nimodipine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Portugal Nimodipine Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.4 Portugal Nimodipine Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Portugal Nimodipine Market - Competitive Landscape |
10.1 Portugal Nimodipine Market Revenue Share, By Companies, 2024 |
10.2 Portugal Nimodipine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here